MK
VRTX icon

MASTERINVEST Kapitalanlage’s Vertex Pharmaceuticals VRTX Stock Holding History

MASTERINVEST Kapitalanlage’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.23M Buy
8,519
+226
+3% +$100K 0.36% 69
2026
Q1 		$3.7M Buy
8,293
+2,749
+50% +$1.28M 0.38% 63
2025
Q4 		$2.52M Hold
5,544
– – 0.24% 100
2025
Q3 		$2.17M Sell
5,544
-240
-4% -$100K 0.21% 111
2025
Q2 		$2.58M Buy
+5,784
New +$2.67M 0.27% 91

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

MASTERINVEST Kapitalanlage's VRTX Position: Q2 2026 in Review

MASTERINVEST Kapitalanlage increased its Vertex Pharmaceuticals (VRTX) stake by 2.7% in Q2 2026, buying an estimated $100K and bringing the position to 8,519 shares worth $4.23M. The position accounts for 0.36% of the portfolio, ranked #69.

MASTERINVEST Kapitalanlage first reported a position in VRTX in Q2 2025 and has held it in 5 quarters since. 1,762 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • MASTERINVEST Kapitalanlage held 8,519 shares of Vertex Pharmaceuticals worth $4.23M as of Q2 2026.
  • MASTERINVEST Kapitalanlage bought 226 Vertex Pharmaceuticals shares in Q2 2026, an estimated $100K.
  • Vertex Pharmaceuticals made up 0.36% of MASTERINVEST Kapitalanlage's portfolio in Q2 2026, its #69 holding.
  • MASTERINVEST Kapitalanlage first reported a position in Vertex Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • 1,762 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on MASTERINVEST Kapitalanlage's 13F filing for Q2 2026, filed 17 Aug 2026.